Advocating AI - driven Digital Pathology 

aetherAI’s mission is to use state-of-the-art information technology to improve standards of healthcare and quality of human life.


  • Taiwan government rolls out Asia Silicon Valley Department Plan 2.0 (2021–2024) to expand AIoT applications, which is expected to encourage a digital transformation in healthcare.  


  • AI-powered detection solutions aetherAI Endo and aetherAI LDCT

  • aetherAI’s annotation-free whole-slide training approach published with global recognition in leading journal Nature Communications

  • Partnership with Novartis Taiwan and Linkou CGMH to use AI to improve diagnosis of blood disease

  • Revenues triple for third year in a row, expanding into global markets

  • TAIPEI Prominent Enterprise Award—R&D Award, Judge’s Award

  • Largest digital pathology project in Taiwan for CGMH Group, Taiwan’s largest private hospital group


  • Implementation of digital pathology for National Taiwan University Hospital, Taiwan’s top medical center

  • Series A from Quanta Computer

  • Introduction of world’s first fully automated AI system for bone marrow differentials

  • The government’s Six Core Strategic Industries Program is created to transform Taiwan’s biotech and medical technology. The inclusion of information and digital technology is expected to boost smart healthcare development.


  • Business Startup Award by Ministry of Economic Affairs, Taiwan, ROC

  • Seed funding round with investment from Cathay Venture

  • Optimized pipelines for training DNNs on whole-slide images


  • Training multiple AI models with top medical centers in the US and Taiwan, including UPMC, National Taiwan University Hospital, Taipei Veterans General Hospital, and CGHM.

  • Meet Neo Star Demo Show Award Winner

  • NVIDIA GTC Inception Award Winner


  • Beginning of collaboration with CGMH, Chang Gung Memorial Hospital, Taiwan’s largest private hospital group

  • Introduction of AI medical imaging development platform


  • 1st project: computer-aided detection of circulating tumor cells on whole slide images



  • Founding of aetherAI

Meet the Team


Joe Yeh

M.D., Co-founder & CEO.

Dr. Joe Yeh holds an M.D. from National Taiwan University and studied for a doctorate in pathology at the University of Southern California, where he discovered his passion for computer programming and image analysis. Inspired by the power of computer algorithms to perform rapid, accurate image analysis and the potential to improve healthcare, Dr. Yeh left academia and founded aetherAI with KJB and Steven Yeh.


Dr. Yeh has taught deep learning in medical imaging at National Taiwan University's Department of Biomedical Engineering and National Cheng Kung University’s Department of Electrical Engineering. He has co-authored several research papers published in prestigious international publications such as Nature Communications.

Steve Yeh

Co-founder and COO

Sean Yu, M.S.

VP of Data Science


Co-founder and CTO

Peichen Lin, M.D., M.S.

VP of Clinical and Regulatory Affairs

Core Business

aetherAI is dedicated to developing solutions for AI-Powered diagnostic support. The company’s mission is to use state-of-the-art technology to elevate standards of medical imaging diagnosis and improve quality of care. Our work focuses on the digital pathology revolution and the use of AI in medical imaging and pharmaceutical and biotech companies.



R&D award,

Judge's award,

TAIPEI Prominent Enterprise Award

截圖 2021-10-01 下午2.38.38.png

Business Startup Award, Ministry of Economic Affairs

Joe Yeh_aetherAI.jpg
截圖 2021-10-01 下午3.19.51.png

10 Coolest Tech Startups by Ministry of Science and Technology


100 MVP Managers, ManagerToday,


Inception Award, NVIDIA GTC

截圖 2021-10-01 下午3.21.43.png

TIEC Special Award, SingularityU APAC Global Impact Challenge

截圖 2021-10-01 下午3.23.42.png


Medical Devices GMP Certification

ISO13485 Certification

Medical Device Manufacturing License

Taiwan FDA Medical Device License

Embracing the Future of Healthcare
through AI Collaboration